Efficacy of endoscopic intermuscular dissection vs. endoscopic submucosal dissection in treating rectal neuroendocrine tumors < 10 mm

Abstract

Background and study aims

Rectal neuroendocrine tumors (r-NETs) exhibit significant heterogeneity and malignant potential. Currently, endoscopic resection is the preferred treatment for r-NETs < 10 mm. However, traditional endoscopic resection carries a risk of positive vertical margins. This study aimed to compare clinical efficacy of endoscopic intermuscular dissection (EID) and endoscopic submucosal dissection (ESD) in treating small r-NETs (< 10 mm).

Patients and methods

This retrospective study included 56 patients with r-NETs < 10 mm who underwent endoscopic treatment between April 2017 and September 2024 at Shenzhen University Affiliated South China Hospital and Shenzhen Hospital of Southern Medical University. All procedures were performed by the same surgeon. Patients were divided into two groups based on type of endoscopic treatment: the EID group (n = 16) and the ESD group (n = 40). We compared operative time, technical success rates, resection outcomes, adverse event (AE) rates, and histopathological findings between the two groups.

Results

Median lesion size in the EID group (7.5 mm) was significantly larger than in the ESD group (6.0 mm) (P = 0.001). Although operative time in the EID group was longer (39 vs 28.5 minutes), the difference was not statistically significant (P = 0.137). The complete resection rate was 100% in the EID group and 97.5% in the ESD group, with no statistically significant difference. There were no significant differences in general characteristics, technical success rates (100% vs 100%), or incidence of AEs (bleeding, perforation, infection) (0% vs 0%) between groups (P > 0.05).

Conclusions

Endoscopic intermuscular dissection offers a better option for preventing positive basal margins and demonstrates good safety and feasibility.

Keywords

Endoscopy Upper GI Tract - Endoscopic resection (ESD, EMRc, ...) - Endoscopy Lower GI Tract - Polyps / adenomas / ... - Endoscopic resection (polypectomy, ESD, EMRc, ...)

Publication History

Received: 22 January 2025

Accepted after revision: 18 June 2025

Accepted Manuscript online:
23 June 2025

Article published online:
06 August 2025

• References

• 1 Cha B, Shin J, Ko WJ. et al. Prognosis of incompletely resected small rectal neuroendocrine tumor using endoscope without additional treatment. BMC Gastroenterol 2022; 22: 293
• 2 Fan JH, Zhang YQ, Shi SS. et al. A nation-wide retrospective epidemiological study of gastroenteropancreatic neuroendocrine neoplasms in China. Oncotarget; 2017; 8: 71699-71708
• 3 Cha B, Shin J, Ko WJ. et al. Prognosis of incompletely resected small rectal neuroendocrine tumor using endoscope without additional treatment. BMC Gastroenterol 2022; 22: 293
• 4 Sekiguchi M, Kawamura T, Horiguchi G. et al. Colorectal neuroendocrine neoplasm detection rate during colonoscopy: Results from large-scale data of colonoscopies in Japan. Am J Gastroenterol 2025; 120: 473-477
• 5 Wu ZJ, Zhou MY, Zheng ZX. et al. Progress in diagnosis and treatment of rectal neuroendocrine neoplasms. Chinese J Oncology 2020; 42: 438-444
• 6 Rinke A, Ambrosini V, Dromain C. et al. European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for colorectal neuroendocrine tumours. J Neuroendocrinol 2023; 35: e13309
• 7 Chinese Society of Clinical Oncology Neuroendocrine Tumor Expert Committee. Consensus on the management of gastroenteropancreatic neuroendocrine tumors in China (2022 edition). Chinese J Oncology 2022; 44: 1305-1329
• 8 Lee HS, Moon HS, Kwon IS. et al. Comparison of conventional and modified endoscopic mucosal resection methods for the treatment of rectal neuroendocrine tumors. Surg Endosc 2021; 35: 6055-6065
• 9 Meier B, Albrecht H, Wiedbrauck T. et al. Full-thickness resection of neuroendocrine tumors in the rectum. Endoscopy 2020; 52: 68-72
• 10 Liao S, Li B, Huang L. et al. Endoscopic intermuscular dissection in the management of a rectal neuroendocrine tumor. Endoscopy 2023; 55: E977-E979
• 11 Chen T, Yao LQ, Xu MD. et al. Efficacy and safety of endoscopic submucosal dissection for colorectal carcinoids. Clin Gastroenterol Hepatol 2016; 14: 575-581
• 12 Ichita C, Sasaki A, Kawachi J. et al. Endoscopic intermuscular dissection for a lower rectal gastrointestinal stromal tumor. Endoscopy 2023; 55: E258-E259
• 13 Dang H, Verhoeven DA, Basiliya K. et al. Endoscopic intermuscular dissection of early anal cancer. Endoscopy 2024; 56: E472-E473
• 14 Dasari A, Shen C, Halperin D. et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol 2017; 3: 1335-1342
• 15 Kooyker AI, Verbeek WH, van den Berg JG. et al. Change in incidence, characteristics and management of colorectal neuroendocrine tumours in The Netherlands in the last decade. United European Gastroenterol J 2020; 8: 59-67
• 16 Taghavi S, Jayarajan SN, Powers BD. et al. Examining rectal carcinoids in the era of screening colonoscopy: a Surveillance, Epidemiology, and End Results analysis. Dis Colon Rectum 2013; 56: 952-959
• 17 Shim KN, Yang SK, Myung SJ. et al. Atypical endoscopic features of rectal carcinoids. Endoscopy 2004; 36: 313-316
• 18 Gallo C, Rossi RE, Cavalcoli F. et al. Rectal neuroendocrine tumors: Current advances in management, treatment, and surveillance. World J Gastroenterol 2022; 28: 1123-1138
• 19 Deng C, Wu S, Liao L. et al. Use of a self-made additional working channel for underwater endoscopic mucosal resection of a rectal neuroendocrine tumor. Endoscopy 2022; 54: E790-E791
• 20 Tribonias G, Komeda Y, Leontidis N. et al. Endoscopic intermuscular dissection (EID) for removing early rectal cancers and benign fibrotic rectal lesions. Tech Coloproctol 2023; 27: 1393-1400
• 21 Ito S, Hotta K, Sekiguchi M. et al. Short-term outcomes of endoscopic resection for colorectal neuroendocrine tumors: Japanese multicenter prospective C-NET STUDY. Dig Endosc 2024; 36: 942-951
• 22 Moons LMG, Bastiaansen BAJ, Richir MC. et al. Endoscopic intermuscular dissection for deep submucosal invasive cancer in the rectum: a new endoscopic approach. Endoscopy 2022; 54: 993-998